Clinical aspects of perimenstrual headaches

Current Pain and Headache Reports

Volumn 13, Issue 1, 2009, Pages 75-81

  Taylor, Frederick R ^a  

^a PARK NICOLLET INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; DROSPIRENONE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FROVATRIPTAN; LEVONORGESTREL; MEFENAMIC ACID; NAPROXEN; NARATRIPTAN; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE;

CLINICAL TRIAL; DISABILITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MOOD CHANGE; MUSCLE CRAMP; PAIN ASSESSMENT; PERIMENSTRUAL HEADACHE; REVIEW; SINUSITIS;

FEMALE; HEADACHE; HUMANS; MIGRAINE WITHOUT AURA; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 59149088329     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0015-z     Document Type: Review

References (33)

1. Allais G, Gabellari IC, Mana O, Benedetto C: Clinical aspects of perimenstrual headache. Curr Headache Rep 2007, 6:146-152.
2. Tepper SJ: Acute treatment of menstrual migraine. Curr Headache Rep 2007, 6:169-173.
3. Hutchinson S: Prevention and management of menstrual migraine. Curr Headache Rep 2007, 6:164-168.
4. Headache Classification of Subcommittee of the International Headache Society (IHS): The International Classification of Headache Disorders-II. Cephalalgia 2004, 24(Suppl 1):9-169.
5. Nett R, Mannix LK, Mueller L, et al.: Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Headache 2008 Apr 14 (Epub ahead of print).
6. Mannix LK, Loder E, Nett R, et al.: Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: Two prospective, randomized, placebo-controlled, doubleblind studies. Cephalalgia 2007, 27:414-421.
7. Diamond ML, Cady RK, Mao L, et al.: Characteristics of migraine attacks and responses to almotriptan treatment: A comparison of menstrually related and nonmenstrually related migraines. Headache 2008, 48:248-258.
8. Mathew NT, Finlayson G, Smith TR, et al.: Early intervention with almotriptan: Results of the AEGIS trial (AXERT Early Migraine Intervention Study). Headache 2007, 47:189-198.
9. Brandes JL: The influence of estrAgen on migraine: a systematic review. JAMA 2006, 295:1824-1830.
10. Stewart WF, Lipton RB, Chee E, et al.: Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000, 55:1517-1523.
11. Granella F, Sances G, Allais G, et al.: Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004, 24:707-716.
12. MacGregor EA, Hackshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351-353.
13. Schreiber CP, Cady RK: Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg. Clin Ther 2007, 29(Suppl):2511-2519.
14. MacGregor EA, Frith A, Ellis J, et al.: Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study. Neurology 2006, 67:2159-2163.
15. Anderson FD, Hait H: A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003, 68:89-96.
16. Anderson FD, Gibbons W, Portman D: Long-term safety of an extended-cycle oral contraceptive (Seasonale): A 2-year multicenter open-label extension trial. Am J Obstet Gynecol 2006, 195:92-96.
17. Anderson FD, Gibbons W, Portman D: Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception 2006, 73:229-234.
18. Sulak P, Willis S, Kuehl T, et al.: Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007, 47:27-37.
19. Coffee AL, Sulak PJ, Kuehl TJ: Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 2007, 75:444-449.
20. Legro RS, Pauli JG, Kunselman AR, et al.: Effects of continuous versus cyclical oral contraception: A randomized controlled trial. J Clin Endocrinol Metab 2008, 93:420-429.
21. Edelman A, Gallo MF, Nichols MD, et al.: Continuous versus cyclic use of combined oral contraceptives for contraception: Systematic Cochrane review of randomized controlled trials. Hum Reprod 2006, 21:573-578.
22. Newman L, Mannix LK, Landy S, et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study. Headache 2001, 41:248-256.
23. Mannix LK, Savani N, Landy S, et al.: Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 2007, 47:1037-1049.
24. Moschiano F, Allais G, Grazzi I, et al.: Naratriptan in the cyclic prophylaxis of pure menstrual migraine. Neurol Sci 2005, 26(Suppl 2):S162-S166.
25. Brandes JL, Smith T, Diamond M, Ames MH: Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache 2007, 47:886-894.
26. Guidotti M, Mauri M, Barrila C, et al.: Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine. J Headache Pain 2007, 8:283-288.
27. Pradalier A, Vincent D, Beaulieu PH, et al.: Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In New Advances in Headache Research, edn 4. Edited by Clifford-Rose F. London: Smith-Gordon; 1994:129-132.
28. Allais G, Bussone G, De Lorenzo C, et al.: Naproxen sodium in short-term prophylaxis of pure menstrual migraine: Pathophysiological and clinical considerations. Neurol Sci 2007, 28(Suppl 2):S225-S228.
29. Pringsheim T, Davenport WJ, Dodick D: Acute treatment and prevention of menstrually related migraine headache: Evidence-based review. Neurology 2008, 70:1555-1563.
30. Allais G, Acuto G, Cabarrocas X, et al.: Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006, 27(Suppl 2):S193-S197.
31. MacGregor EA, Keywood C: Frovatriptan is effective in menstrually associated migraine [abstract]. Cephalalgia 2000, 20:345.
32. Tepper SJ: Treatment of menEtrual migraine: evidencebased review. Manag Care 2007, 16(Suppl 7):10-14.
33. Tuchman MM, Hee A, Emeribe U, Silberstein S: Oral zolmitriptan in the short-term prevention of menstrual migraine: A randomized, placebo-controlled study. CNS Drugs 2008, 22:877-886.